News

CUTISS reaches milestone: publication of Phase I of the Clinical Studies of denovoSkin!

The denovoFix transport box was developed by Astrid Welti as a Bachelor Thesis in cooperation with the Zürcher Hochschule der Künste (ZHdK).

CUTISS AG receives SME Instrument Grant for 2.5 Million Euros to automate.

Read more about this on startupticker.ch –

Cutiss, SamanTree Medical and RqMicro have been selected for the SME Instrument. The startups will be supported in the Phase 2 of the SMI Instrument, with up to €2.5 million in funding.

CUTISS AG is among the 10 Swiss Venture Leaders that will fly to Boston!

Ten new startups have been selected to become the next Venture Leaders Life Sciences 2018. Chosen from among the most promising Life Sciences startups in Switzerland, the team will embark on a fully packed one-week roadshow in Boston. Meet the team at the Startup Champions Seed Night event on May 2nd.
Following in the footsteps of fellow alumni like Insphero or Covagen, the Venture Leaders Life Sciences 2018 team members will join the 17th edition for a deep dive into Boston’s Life Sciences industry between May 27th and June 3rd. For an intense week, the newly constituted Swiss National Startup Team will have the opportunity to build a solid network through exchanges with local peers, meetings with key Medtech and Biotech industry leaders, and pitches in front of investors, all in order to boost their global expansion ambitions. The Boston region is considered to be one of the major Life Sciences hub worldwide, representing an ideal environment for the Swiss-based startups to get exposure and visibility as well showcasing Switzerland as a breeding ground for innovation in Life Sciences.

University of Zurich receives Swissmedic approval to commence phase II denovoSkin™ trial for reconstructive surgery in adults and children.

Project by CUTISS AG at ETH Industry day 2017

What a great entrance in the ranking!

Article about CUTISS in the International journal of science

“Clinical devices and services: Repair shops

Advances in materials and techniques are restoring damaged body parts to full function.”

denovoSkin™ is a project of the Wyss Zurich, the joint accelerator of the University of Zurich and ETH Zurich (Swiss Federal Institute of Technology Zurich), which was made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. h.c. mult. Hansjörg Wyss. It was established to foster translational research focused on developing treatment protocols and clinical therapies, as well as novel technologies and intelligent systems, in the emerging fields of Regenerative Medicine and Robotics, and hybrid technologies thereof.
Wyss Zurich unites world-leading experts from both institutions in multidisciplinary teams, pooling their knowledge and expertise.

CUTISS at >> venture >> Play